News | March 30, 2009

Varian’s VariSeed 8.0 Aims to Simplify Brachytherapy Treatment Planning

March 31, 2009 - Prostate cancer patients have begun receiving brachytherapy using new treatment planning software that aims to enable improvements in the precision and speed of the treatment process.

VariSeed 8.0 from Varian Medical Systems is an updated version of the company's treatment planning software for Low Dose Rate (LDR) brachytherapy in which radiation doses are delivered by implanting seeds within the prostate.

With VariSeed 8.0, doctors reportedly can use the new software to target individual sectors of the prostate based on biopsy results.

"We have also speeded up the planning process considerably with an improved SeedFinder algorithm," said Rebecca Claydon, software product manager with Varian's brachytherapy business unit. "The use of a 3-D Digital Reconstructed Radiograph (DRR) generated from a CT allows doctors to more easily see and interactively add or remove proposed seed locations from the treatment plan."

According to William Bice, M.D, recently at the University of Texas Health Science Center at San Antonio but now practicing at The London Clinic in England, the main benefit of VariSeed 8.0 over previous versions of the product is its ability to perform sector analysis. "The new version of VariSeed features some significant improvements in several different areas, particularly the ability to target regions using sector analysis," said Dr. Bice. "It is now easier to verify seed locations following source localization and reconstruction using the projection display in VariSeed 8.0."

For more information: www.varian.com

Related Content

California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017
iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct intraoperative radiation...
Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Electronic Brachytherapy Comparable to Mohs Surgery in Early-Stage Non-Melanoma Skin Cancer Treatment
News | Brachytherapy Systems | July 20, 2017
July 20, 2017 — Rates of recurrence in early-stage non-melanoma skin cancer (NMSC) patients were virtually identical
iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference
News | Brachytherapy Systems | March 15, 2017
CAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative...
prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...
Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer
News | Brachytherapy Systems | January 16, 2017
On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive electronic...
Overlay Init